Gossamer Bio, Inc. (GOSS) Form 8-K — Sep 16, 2026
Gossamer Bio appointed Gregory A. Ciongoli to its Board of Directors as a Class III director effective September 16, 2026, with a term expiring at the 2027 annual meeting, and named him to the Audit Committee. The Board determined he qualifies as an independent director under Nasdaq listing requirements. Ciongoli, 51, is Founder and Managing Partner of Adiumentum Capital Management and was a Partner at the Baupost Group from 2007 to 2024.
Key figures
- Director age
- 51
- Reverse split date
- 2026-09-10
- Reverse split ratio
- 1:80
- Board annual retainer usd
- 40000
- Pipe initial closing date
- 2026-08-24
- Audit committee annual retainer usd
- 7500
- Second closing assumed warrant price usd
- 11.192
- Ciongoli second closing common share equiv
- 111687
- Ciongoli initial closing common share equiv
- 22337
- Series a1 preferred pre approval share equiv
- 250
- Series a2 preferred pre approval share equiv
- 1250
- Series a3 preferred pre approval share equiv
- 1000
- Ciongoli fda approval warrant common share equiv
- 66845
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.